These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 30917868)

  • 1. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.
    Chen HA; Hsu TC; Yang SC; Weng CT; Wu CH; Sun CY; Lin CY
    Arthritis Res Ther; 2019 Mar; 21(1):82. PubMed ID: 30917868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry.
    Hachulla E; Jais X; Cinquetti G; Clerson P; Rottat L; Launay D; Cottin V; Habib G; Prevot G; Chabanne C; Foïs E; Amoura Z; Mouthon L; Le Guern V; Montani D; Simonneau G; Humbert M; Sobanski V; Sitbon O;
    Chest; 2018 Jan; 153(1):143-151. PubMed ID: 28851621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan.
    Lin CY; Ko CH; Hsu CY; Chen HA
    Semin Arthritis Rheum; 2020 Oct; 50(5):957-962. PubMed ID: 32906031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
    Zhao J; Wang Q; Liu Y; Tian Z; Guo X; Wang H; Lai J; Huang C; Yang X; Li M; Zeng X
    Int J Cardiol; 2017 Jun; 236():432-437. PubMed ID: 28159359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
    Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
    Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus-pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medical Data Vision Database in Japan.
    Atsumi T; Tan JY; Chiang AP; Yu DY; Makanji Y; Wu DB; Casorso J; Kouhkamari M; Lim S
    Mod Rheumatol; 2024 Jul; 34(4):741-749. PubMed ID: 37747781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model.
    Dai M; Zhang C; Li C; Wang Q; Gao C; Yue R; Yao M; Su Z; Zheng Z
    Arthritis Res Ther; 2023 Aug; 25(1):155. PubMed ID: 37612772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of systemic lupus erythematosus and sleep disorders: a nationwide population-based cohort study.
    Chung WS; Lin CL; Kao CH
    Lupus; 2016 Apr; 25(4):382-8. PubMed ID: 26585071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
    Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
    Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis.
    Liu Y; Cheng Z; Zha B; Chen X; Gong Z; Ji L; Wei L
    Lupus; 2023 Oct; 32(11):1310-1319. PubMed ID: 37699157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
    Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
    Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Qu J; Li M; Zhang X; Zhang M; Zuo X; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Qian J; Huang C; Zhao J; Wang Q; Liu Y; Tian Z; Wang Y; Wei W; Zeng X
    Respir Res; 2023 Sep; 24(1):220. PubMed ID: 37689662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
    Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
    Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines.
    Li Y; Qian J; Dong X; Zhao J; Wang Q; Wang Y; Zeng X; Tian Z; Li M
    Arthritis Res Ther; 2024 May; 26(1):109. PubMed ID: 38802957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for concomitant pulmonary arterial hypertension at diagnosis of systemic lupus erythematosus in a Chinese population.
    Pan Y; Sun Y; He L
    Int J Rheum Dis; 2022 Jan; 25(1):76-82. PubMed ID: 34796660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
    Lun X; Yang J; Liu Y; Zhao F; Wei Z; Sun Y; Zhou X
    Medicine (Baltimore); 2023 Dec; 102(51):e36654. PubMed ID: 38134088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients.
    Donnarumma JFS; Ferreira EVM; Ota-Arakaki J; Kayser C
    Adv Rheumatol; 2019 Jan; 59(1):1. PubMed ID: 30657102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.
    Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ
    Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
    J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
    Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
    J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.